Joywell, a biotech startup that makes protein-based alternative sugar, tells Axios it raised $25 million in Series B funding.
Why it matters: The alternative foods industry doesn't have quite the shine it used to, but the ongoing blurring of lines between food production and biotech could revitalize investor interest in the space.
